10.1038/sj.bjp.0703256 82
Hellstrom PM, Hein J, Bytzer P, Bjornsson E, Kristensen J, Schambye H (2009) Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
Unfortunately, it is common for discontinuation to lead to weight gain
From the outset, Smith was interested in asking the mechanistic questions to work out why some people respond to a particular drug and some dont. The EMI post allowed Smith to develop her own ideas and to take on her first role as Chief Investigator in a national study, looking at responses to vaccines in vasculitis patients
Due to the phentermine component, Qsymia is classified as a Schedule IV controlled substance